Binding agents other than antibodies or aptamers may be utilized, so long as there exists a molecular binding partner or specific binding partner (i.e., binding agent and corresponding target molecule), such that the binding agent undergoes detectable change(s) in physical properties in the presence of its binding partner (the target molecule).